Inhibition by anandamide of 6-hydroxydopamine-induced cell death in PC12 cells

International Journal of Cell Biology

Volumn , Issue , 2010, Pages

  Gorman, Adrienne M ^a   Mnich, Katarzyna ^a   Finn, David P ^a   Dowd, Eilis ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; ANANDAMIDE; BIM PROTEIN; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; OXIDOPAMINE; PHOSPHATIDYLINOSITOL 3 KINASE; STRESS ACTIVATED PROTEIN KINASE; VANILLOID RECEPTOR 1;

ANIMAL CELL; ARTICLE; ENZYME ACTIVATION; ENZYME INHIBITION; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

RATTUS;

EID: 77955948472     PISSN: 16878876     EISSN: 16878884     Source Type: Journal    
DOI: 10.1155/2010/818497     Document Type: Article

References (61)

1. evk J., Maek K., Potential role of cannabinoids in Parkinsons disease Drugs and Aging 2000 16 6 391 395
2. Romero J., Lastres-Becker I., de Miguel R., Berrendero F., Ramos J. A., Fernndez-Ruiz J., The endogenous cannabinoid system and the basal ganglia: biochemical, pharmacological, and therapeutic aspects Pharmacology and Therapeutics 2002 95 2 137 152
3. Brotchie J. M., CB 1 cannabinoid receptor signalling in Parkinsons disease Current Opinion in Pharmacology 2003 3 1 54 61
4. Fernndez-Ruiz J., Romero J., Velasco G., Toln R. M., Ramos J. A., Guzmn M., Cannabinoid CB 2 receptor: a new target for controlling neural cell survival? Trends in Pharmacological Sciences 2007 28 1 39 45
5. Jimenez-Del-Rio M., Daza-Restrepo A., Velez-Pardo C., The cannabinoid CP55,940 prolongs survival and improves locomotor activity in Drosophila melanogaster against paraquat: implications in Parkinsons disease Neuroscience Research 2008 61 4 404 411
6. Devane W. A., Hanus L., Breuer A., Isolation and structure of a brain constituent that binds to the cannabinoid receptor Science 1992 258 5090 1946 1949
7. Fride E., Mechoulam R., Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent European Journal of Pharmacology 1993 231 2 313 314
8. Smart D., Gunthorpe M. J., Jerman J. C., The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1) British Journal of Pharmacology 2000 129 2 227 230
9. Matas D., Juknat A., Pietr M., Klin Y., Vogel Z., Anandamide protects from low serum-induced apoptosis via its degradation to ethanolamine Journal of Biological Chemistry 2007 282 11 7885 7892
10. Shouman B., Fontaine R. H., Baud O., Endocannabinoids potently protect the newborn brain against AMPA-kainate receptor-mediated excitotoxic damage British Journal of Pharmacology 2006 148 4 442 451
11. Sinor A. D., Irvin S. M., Greenberg D. A., Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats Neuroscience Letters 2000 278 3 157 160
12. Schomacher M., Mller H. D., Sommer C., Schwab S., Schbitz W.-R., Endocannabinoids mediate neuroprotection after transient focal cerebral ischemia Brain Research 2008 1240 213 220
13. Contassot E., Wilmotte R., Tenan M., Arachidonylethanolamide induces apoptosis of human glioma cells through vanilloid receptor-1 Journal of Neuropathology and Experimental Neurology 2004 63 9 956 963
14. Maccarrone M., Lorenzon T., Bari M., Melino G., Finazzi-Agro A., Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors Journal of Biological Chemistry 2000 275 41 31938 31945
15. Veldhuis W. B., van der Stelt M., Wadman M. W., Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases Journal of Neuroscience 2003 23 10 4127 4133
16. Thoenen H., Tranzer J. P., Chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-hydroxydopamine Naunyn-Schmiedebergs Archiv fr Pharmakologie und Experimentelle Pathologie 1968 261 3 271 288
17. Blum D., Torch S., Lambeng N., Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinsons disease Progress in Neurobiology 2001 65 2 135 172
18. Lotharius J., Dugan L. L., OMalley K. L., Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons Journal of Neuroscience 1999 19 4 1284 1293
19. Han B. S., Hong H.-S., Choi W.-S., Markelonis G. J., Oh T. H., Oh Y. J., Caspase-dependent and -independent cell death pathways in primary cultures of mesencephalic dopaminergic neurons after neurotoxin treatment Journal of Neuroscience 2003 23 12 5069 5078
20. Choi W.-S., Yoon S.-Y., Oh T. H., Choi E.-J., OMalley K. L., Oh Y. J., Two distinct mechanisms are involved in 6-hydroxydopamine- and MPP+induced dopaminergic neuronal cell death: role of caspases, ROS, and JNK Journal of Neuroscience Research 1999 57 1 86 94
21. Walkinshaw G., Waters C. M., Neurotoxin-induced cell death in neuronal PC12 cells is mediated by induction of apoptosis Neuroscience 1994 63 4 975 987
22. Gorman A. M., Szegezdi E., Quigney D. J., Samali A., Hsp27 inhibits 6-hydroxydopamine-induced cytochrome c release and apoptosis in PC12 cells Biochemical and Biophysical Research Communications 2005 327 3 801 810
23. Mosmann T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays Journal of Immunological Methods 1983 65 1-2 55 63
24. Nicholson D. W., Ali A., Thornberry N. A., Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis Nature 1995 376 6535 37 43
25. Gorman A. M., Hirt U. A., Zhivotovsky B., Orrenius S., Ceccatelli S., Application of a fluorometric assay to detect caspase activity in thymus tissue undergoing apoptosis in vivo Journal of Immunological Methods 1999 226 1-2 43 48
26. Sarker K. P., Maruyama I., Anandamide induces cell death independently of cannabinoid receptors or vanilloid receptor 1: possible involvement of lipid rafts Cellular and Molecular Life Sciences 2003 60 6 1200 1208
27. Someya A., Kunieda K., Akiyama N., Hirabayashi T., Horie S., Murayama T., Expression of vanilloid VR1 receptor in PC12 cells Neurochemistry International 2004 45 7 1005 1010
28. Lastres-Becker I., Molina-Holgado F., Ramos J. A., Mechoulam R., Fernndez-Ruiz J., Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinsons disease Neurobiology of Disease 2005 19 1-2 96 107
29. Glinka Y., Gassen M., Youdim M. B. H., Mechanism of 6-hydroxydopamine neurotoxicity Journal of Neural Transmission, Supplement 1997 50 55 66
30. Cavanaugh J. E., Jaumotte J. D., Lakoski J. M., Zigmond M. J., Neuroprotective role of ERK1/2 and ERK5 in a dopaminergic cell line under basal conditions and in response to oxidative stress Journal of Neuroscience Research 2006 84 6 1367 1375
31. Lu Z., Xu S., ERK1/2 MAP kinases in cell survival and apoptosis IUBMB Life 2006 58 11 621 631
32. Szegezdi E., Reed Herbert K., Kavanagh E. T., Samali A., Gorman A. M., Nerve growth factor blocks thapsigargin-induced apoptosis at the level of the mitochondrion viaregulation of Bim Journal of Cellular and Molecular Medicine 2008 12 6A 2482 2496
33. Eminel S., Klettnert A., Roemer L., Herdegen T., Waetzig V., JNK2 translocates to the mitochondria and mediates cytochrome c release in PC12 cells in response to 6-hydroxydopamine Journal of Biological Chemistry 2004 279 53 55385 55392
34. Chetsawang B., Govitrapong P., Ebadi M., The neuroprotective effect of melatonin against the induction of c-Jun phosphorylation by 6-hydroxydopamine on SK-N-SH cells Neuroscience Letters 2004 371 2-3 205 208
35. Lee H. J., Noh Y. H., Lee D. Y., Baicalein attenuates 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells European Journal of Cell Biology 2005 84 11 897 905
36. Tian L.-L., Zhou Z., Zhang Q., Protective effect of () isoborneol against 6-OHDA-induced apoptosis in SH-SY5Y cells Cellular Physiology and Biochemistry 2007 20 6 1019 1032
37. Chao J., Yu M.-S., Ho Y.-S., Wang M., Chang R. C.-C., Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity Free Radical Biology and Medicine 2008 45 7 1019 1026
38. Bogoyevitch M. A., Kobe B., Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases Microbiology and Molecular Biology Reviews 2006 70 4 1061 1095
39. Biswas S. C., Greene L. A., Nerve growth factor (NGF) down-regulates the Bcl-2 homology 3 (BH3) domain-only protein Bim and suppresses its proapoptotic activity by phosphorylation Journal of Biological Chemistry 2002 277 51 49511 49516
40. Becker E. B. E., Howell J., Kodama Y., Barker P. A., Bonni A., Characterization of the c-Jun N-terminal kinase-BimEL signaling pathway in neuronal apoptosis Journal of Neuroscience 2004 24 40 8762 8770
41. Guzmn M., Snchez C., Galve-Roperh I., Control of the cell survival/death decision by cannabinoids Journal of Molecular Medicine 2001 78 11 613 625
42. Rueda D., Navarro B., Martnez-Serrano A., Guzmn M., Galve-Roperh I., The endocannabinoid anandamide inhibits neuronal progenitor cell differentiation through attenuation of the Rap1/B-Raf/ERK pathway Journal of Biological Chemistry 2002 277 48 46645 46650
43. Mechoulam R., Panikashvili D., Shohami E., Cannabinoids and brain injury: therapeutic implications Trends in Molecular Medicine 2002 8 2 58 61
44. Cravatt B. F., Giang D. K., Mayfield S. P., Boger D. L., Lerner R. A., Gilula N. B., Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides Nature 1996 384 6604 83 87
45. Ouyang M., Shen X., Critical role of ASK1 in the 6-hydroxydopamine- induced apoptosis in human neuroblastoma SH-SY5Y cells Journal of Neurochemistry 2006 97 1 234 244
46. Wilhelm M., Xu Z., Kukekov N. V., Gire S., Greene L. A., Proapoptotic nix activates the JNK pathway by interacting with POSH and mediates death in a Parkinson disease model Journal of Biological Chemistry 2007 282 2 1288 1295
47. Rodriguez-Blanco J., Martn V., Herrera F., Garca-Santos G., Antoln I., Rodriguez C., Intracellular signaling pathways involved in post-mitotic dopaminergic PC12 cell death induced by 6-hydroxydopamine Journal of Neurochemistry 2008 107 1 127 140
48. Cohen G., Heikkila R. E., The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6 hydroxydopamine, dialuric acid, and related cytotoxic agents Journal of Biological Chemistry 1974 249 8 2447 2452
49. Izumi Y., Sawada H., Sakka N., p-quinone mediates 6-hydroxydopamine- induced dopaminergic neuronal death and ferrous iron accelerates the conversion of p-quinone into melanin extracellularly Journal of Neuroscience Research 2005 79 6 849 860
50. Saito Y., Nishio K., Ogawa Y., Molecular mechanisms of 6-hydroxydopamine-induced cytotoxicity in PC12 cells: involvement of hydrogen peroxide-dependent and -independent action Free Radical Biology and Medicine 2007 42 5 675 685
51. Bouaboula M., Poinot-Chazel C., Bourri B., Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB 1 Biochemical Journal 1995 312, part 2 637 641
52. Snchez M. G., Ruiz-Llorente L., Snchez A. M., Daz-Laviada I., Activation of phosphoinositide 3-kinase/PKB pathway by CB 1 and CB 2 cannabinoid receptors expressed in prostate PC-3 cells. Involvement in Raf-1 stimulation and NGF induction Cellular Signalling 2003 15 9 851 859
53. Dhanasekaran D. N., Reddy E. P., JNK signaling in apoptosis Oncogene 2008 27 48 6245 6251
54. Eminel S., Roemer L., Waetzig V., Herdegen T., c-Jun N-terminal kinases trigger both degeneration and neurite outgrowth in primary hippocampal and cortical neurons Journal of Neurochemistry 2008 104 4 957 969
55. Qi X.-J., Wildey G. M., Howe P. H., Evidence that Ser87 of BimEL is phosphorylated by Akt and regulates BimEL apoptotic function Journal of Biological Chemistry 2006 281 2 813 823
56. Putcha G. V., Le S., Frank S., JNK-mediated BIM phosphorylation potentiates BAX-dependent apoptosis Neuron 2003 38 6 899 914
57. Rueda D., Galve-Roperh I., Haro A., Guzman M., The CB 1 cannabinoid receptor is coupled to the activation of c-jun N-terminal kinase Molecular Pharmacology 2000 58 4 814 820
58. Downer E. J., Fogarty M. P., Campbell V. A., Tetrahydrocannabinol-induced neurotoxicity depends on CB 1 receptor-mediated c-Jun N-terminal kinase activation in cultured cortical neurons British Journal of Pharmacology 2003 140 3 547 557
59. Sarker K. P., Biswas K. K., Yamakuchi M., ASK1-p38 MAPK/JNK signaling cascade mediates anandamide-induced PC12 cell death Journal of Neurochemistry 2003 85 1 50 61
60. Ruiz L., Miguel A., Daz-Laviada I., 9-tetrahydrocannabinol induces apoptosis in human prostate PC-3 cells via a receptor-independent mechanism FEBS Letters 1999 458 3 400 404
61. Velasco L., Ruiz L., Snchez M. G., Daz-Laviada I., 9-tetrahydrocannabinol increases nerve growth factor production by prostate PC-3 cells: involvement of CB 1 cannabinoid receptor and Raf-1 European Journal of Biochemistry 2001 268 3 531 535